abil
virus
transfer
macromolecul
cell
make
attract
start
point
design
biolog
deliveri
vehicl
virusbas
vector
subvir
system
alreadi
find
biotechnolog
medic
applic
gene
peptid
vaccin
drug
deliveri
progress
made
understand
cellular
molecular
mechan
underli
viru
entri
particularli
identifi
viru
receptor
howev
receptor
bind
first
step
understand
molecul
facilit
entri
envelop
virus
fuse
cell
nonenvelop
virus
penetr
cell
membran
happen
follow
penetr
detail
analys
full
potenti
virus
vector
deliveri
vehicl
realis
discuss
aspect
entri
mechan
sever
wellcharacteris
viral
system
attempt
provid
fulli
comprehens
review
viru
entri
focu
primarili
envelop
virus
cess
entri
vehicl
cell
thu
detail
understand
viru
entri
may
suggest
current
virus
use
deliveri
vehicl
way
exist
deliveri
system
two
differ
way
firstli
viral
genom
improv
novel
one
develop
manipul
foreign
gene
insert
modifi
genom
packag
gener
viru
particl
resembl
origin
virus
strategi
viru
entri
virion
follow
pathway
use
parent
viru
infect
target
cell
system
well
viru
entri
involv
bind
virion
establish
retrovir
vector
varieti
surfac
appropri
cell
deliveri
viru
system
includ
adeno
adenoassocivir
nucleic
acid
cytoplasm
nucleu
ate
viru
alpha
vaccinia
herp
viru
cell
frequent
virus
taken
endocytosi
altern
strategi
compon
deem
rehowev
virion
within
membranebound
endocyt
quir
viral
entri
isol
use
vesicl
remain
topolog
outsid
cytoplasm
facilit
deliveri
exampl
influenza
enuntil
event
lead
penetr
trigger
velop
glycoprotein
haemagglutinin
ha
review
use
term
penetr
use
make
virosom
liposom
contain
redescrib
process
wherebi
viral
nucleic
acid
constitut
viral
membran
protein
transfer
across
cellular
membran
load
peptid
drug
dna
etc
cytosol
target
cell
term
internalis
effect
fusion
origin
virion
reserv
endocytosi
virion
process
peptid
repres
ha
fumay
may
lead
product
infect
sion
motif
coupl
dna
use
constitut
viral
entri
deliv
gene
tissu
cultur
cell
similarli
inactiv
adenovirusliganddna
envelop
virus
gate
viru
act
carrier
infecti
particl
develop
alvirus
evolv
mani
strategi
invad
though
system
work
well
tissu
cultur
cell
case
cellular
molecular
case
vivo
lack
specif
detail
reason
well
understood
effici
requir
clinic
applic
mani
virus
littl
known
nevertheless
wellstudi
case
limit
associ
prosystem
establish
paradigm
virus
compar
entri
strategi
target
membran
socal
vesicl
v
use
differ
virus
determin
primarili
target
snare
implic
structur
viru
virus
either
enreceptor
ensur
transport
vesicl
fuse
velop
nonenvelop
envelop
virus
concorrect
compart
similarli
membran
tain
viral
genom
core
protein
wrap
envelop
virus
must
also
contain
comwithin
one
membran
membran
ponent
requir
bind
ii
fuse
acquir
host
cell
viru
assembl
target
cell
bud
mani
envelop
virus
orthomyxo
eg
influenza
paramyxo
eg
nonenvelop
virus
sendai
rhabdo
eg
vesicular
stomat
viru
retro
eg
human
immunodefici
hiv
per
definit
nonenvelop
virus
conalphavirus
eg
semliki
forest
viru
sfv
tain
membran
though
rotavirus
may
transient
contain
singl
membran
virus
acquir
membran
bud
er
herp
viru
may
undergo
sever
bud
lose
membran
subsequ
matur
fusion
step
differ
intracellular
membran
viral
genom
incorpor
compart
final
acquir
singl
memprotein
shell
cytoplasm
nucleoplasm
brane
exocyt
pathway
contrast
vacinfect
cell
assembl
virion
cinia
viru
member
poxvirus
acquir
releas
cell
lysi
rotavirus
secret
sever
membran
interact
differ
like
viral
envelop
outer
protein
shell
membran
compart
infect
cell
nonenvelop
virus
must
contain
necessari
composit
viral
memmolecular
equip
get
cell
howev
brane
vari
differ
virus
determin
unlik
envelop
virus
nonenvelop
virus
complement
viral
encod
membran
must
reli
strategi
fusion
gener
envelop
protein
ii
content
host
cell
protein
protein
complex
spontaneouslipid
protein
latter
reflect
degre
ly
transport
across
membran
requir
complex
cellular
protein
incorpor
molecular
machin
transloc
mechabud
virion
ii
composit
nism
protein
shell
nonenmembran
system
bud
occur
differ
velop
virus
interact
cell
membran
virus
assembl
bud
differ
cellular
locawel
understood
singl
principl
tion
exampl
endoplasm
reticulum
er
analog
fusion
picornavirus
bind
cellintermedi
compart
golgi
apparatu
plassurfac
compon
dock
canyonlik
membran
depress
surfac
virion
envelop
virus
use
membran
fusion
penefollow
endocytosi
virion
appear
gener
trate
cell
viral
membran
fuse
pore
endosom
membran
allow
viral
cellular
membran
genomecontain
rna
exit
virion
penetr
viral
capsid
core
transfer
cytosol
cytoplasm
without
complet
disassembl
membran
fusion
one
frequent
recapsid
disrupt
endosom
membran
action
occur
eukaryot
cell
celltocel
receptor
bind
may
initi
chang
fusion
spermoocyt
myoblast
fusion
capsid
structur
facilit
pore
format
topolog
close
relat
viru
entri
contrast
adenovirus
employ
fibr
project
howev
membran
fusion
event
occur
higher
virion
surfac
bind
cellular
receptor
frequenc
insid
cell
vesicl
transport
memaft
initi
adsorpt
cell
surfac
adenobran
cargo
intracellular
organel
virus
bind
vitronectinbind
integrin
form
consum
principl
cycl
undergo
endocytosi
coat
vesicl
within
viru
assembl
fusion
similar
endosom
low
ph
activ
lysin
viru
transport
vesicl
format
consumpt
rethat
disrupt
endosom
membran
allow
centli
membran
protein
transport
vesicl
virion
endosom
content
cytoplasm
viral
capsid
subsequ
disepsteinbarr
viru
appear
use
endocyt
assembl
rout
infect
lymphocyt
fuse
surfac
epitheli
cell
similarli
murin
ecotrop
retroviru
appar
phindepend
cellular
site
penetr
aciddepend
entri
cell
type
phdepend
other
versu
acidindepend
penetr
caus
differ
unclear
penetr
may
depend
condit
although
envelop
nonenvelop
virus
ph
intracellular
organel
exampl
endous
differ
mechan
enter
cell
penetr
somal
proteas
suggest
activ
occur
either
cell
surfac
endocyt
moloney
murin
leukemia
viru
fusion
thu
organel
mainli
earli
late
endosom
although
phdepend
virus
penetr
site
use
vari
differ
viru
endocyt
organel
assum
famili
fusion
reaction
envelop
virus
phindepend
virus
penetr
cell
mediat
specif
viral
encod
envelop
surfac
protein
fusion
protein
display
virion
metast
form
must
activ
initi
fusion
alpha
orthomyxo
weak
base
agent
rais
dovirus
least
fusion
trigger
exposur
ph
acid
organel
fusion
protein
low
ph
thu
usual
occur
virion
undergon
endocytosi
mani
phdepend
virus
entri
acid
endocyt
organel
fusion
activ
investig
use
weak
base
ionophor
specif
earli
ph
late
endosom
ph
deinhibitor
vacuolartyp
h
atpas
vatpas
pend
ph
requir
specif
enzym
respons
acidif
intracelenvelop
protein
virus
endocytosi
lular
organel
bafilomycin
coni
essenti
infect
canamycin
though
mode
action
differ
envelop
virus
phdepend
agent
rais
ph
acid
organel
entri
coronavirus
paramyxovirus
well
inhibit
phdepend
viral
penetr
retrovirus
includ
primat
immunothey
directli
affect
phindepend
virus
defici
virus
simian
though
may
influenc
infect
indirectli
immunodefici
virus
siv
requir
low
modul
endosom
ph
exampl
ph
activ
fusion
fusion
trigger
affect
vesicular
transport
endocyt
comcas
unknown
may
involv
interact
partment
weak
base
primaquin
interfer
viral
envelop
protein
specif
receptor
see
recycl
endosom
neutralisabelow
phindepend
virus
appear
tion
endosom
appear
inhibit
transport
capabl
fusion
across
rang
ph
valu
earli
late
endosom
circumst
may
potenti
fuse
cell
surfac
blockad
latter
step
use
specif
within
endocyt
organel
ph
optimum
antibodi
inhibit
vesicular
stomat
viru
celltocel
fusion
mediat
envelop
protein
infect
thu
perturb
intracellular
env
cell
lineadapt
strain
around
transport
agent
neutralis
intracellular
orph
well
ph
endosom
ganel
may
prevent
virus
reach
site
strain
enter
cell
necessari
penetr
infect
phneufus
cell
surfac
howev
tralis
agent
also
perturb
assembl
phdepend
strain
viru
virus
neutralis
exocyt
compart
unknown
given
observ
hiv
cell
see
exampl
ref
thu
entri
endocyt
organel
variou
cell
type
experi
use
releas
infecti
viru
remain
possibl
may
use
readout
design
agent
endocyt
rout
infect
present
time
viru
entri
capac
viru
replic
specif
type
cell
ie
enter
subsequ
produc
viru
entri
initi
virion
first
bind
infecti
progeni
viru
although
use
speth
surfac
potenti
host
cell
event
cific
receptor
account
viral
tropism
mani
occur
first
encount
unclear
instanc
post
entri
effect
also
respons
like
vari
differ
virus
viral
attach
see
exampl
ref
mediat
one
hand
bind
protein
expos
surfac
viru
particl
refer
viral
attach
protein
vap
viral
attach
proteinsvap
viru
receptor
express
target
envelop
virus
attach
cell
surfac
receptor
cell
fig
idea
specif
cell
surfac
one
envelop
glycoprotein
compon
could
use
viru
receptor
mani
virus
contain
singl
speci
eniniti
propos
explain
viral
tropismth
velop
glycoprotein
complex
must
mediat
receptor
bind
fusion
function
eg
ever
yet
method
translat
spike
glycoprotein
complex
alphavirus
bind
constant
function
affin
trimer
glycoprotein
g
protein
rhabdovirus
whole
virion
receptorposit
cell
primat
lentivirus
carri
one
speci
viral
potenti
multival
interact
encod
envelop
protein
pick
rang
cellular
protein
assembl
viru
receptor
includ
mhc
class
ii
antigen
although
essenti
addit
protein
may
facilit
tabl
list
cell
surfac
compon
bind
host
cell
may
target
role
envelop
viru
entri
antibodi
appar
antivir
activ
establish
tabl
indic
virus
use
paramyxovirus
bind
fusion
pera
varieti
differ
surfac
moieti
includ
form
differ
protein
complex
glycoprotein
glycolipid
phospholipid
though
virus
herp
may
carri
sever
differ
major
glycoprotein
representavap
fusion
protein
tive
class
protein
use
singl
date
bestcharacteris
vap
influenza
pass
type
integr
membran
protein
eg
viru
ha
pocket
globular
head
multispan
protein
eg
amino
acid
transport
subunit
bind
termin
sialicacid
residu
glycophosphatidylinositol
gpi
link
protein
oligosaccharid
attach
cell
surfac
glycolipid
eg
low
densiti
lipoprotein
receptor
ldlr
glycoprotein
structur
ha
relat
protein
mani
viru
receptor
member
strain
influenza
viru
complex
immunoglobulin
super
famili
molecul
sialyllactos
resolv
xray
diffract
often
implic
recognit
event
other
structur
sialic
acid
complet
fill
pocket
transport
compon
glycocalyx
adhes
coordin
residu
line
caviti
molecul
etc
among
receptor
retrovirus
receptor
interact
canyonlik
alon
molecul
multimembranespansit
surfac
picornavirus
particular
ning
transport
glycolipidanchor
homorhinovirus
also
structur
determin
logu
ldlr
use
virus
similar
crystallographi
electron
microscopi
sutm
complex
dispar
notwithstand
mani
virus
howev
inon
unifi
trait
among
interact
format
receptor
bind
less
direct
suggest
three
crucial
residu
ecoexampl
extens
studi
env
use
tropic
mulv
receptor
cation
amino
acid
transporsolubl
form
major
receptor
viru
ter
alv
receptor
ldlrrelat
protein
antienv
monoclon
antibodi
encompass
one
aromat
residu
least
one
identifi
continu
discontinu
epitop
charg
residu
may
reflect
similar
like
involv
bind
ref
welladapt
mode
viral
receptor
bind
refer
therein
studi
suggest
bind
site
assembl
differ
region
overal
clear
pattern
usag
molecul
far
apart
particular
class
cell
surfac
molecul
speon
linear
sequenc
cific
virus
viru
famili
perhap
vapreceptor
bind
interact
exsurpris
phdepend
virus
replor
use
intact
viru
solubl
form
strict
use
receptor
contain
well
charactervap
receptor
hiv
endocytosi
motif
inde
polioviru
infect
interact
among
intens
studi
phdepend
mediat
number
differ
prepar
polioviru
receptor
lack
cytoplasm
tail
dissoci
constant
monomer
su
suggest
cell
surfac
molecul
bind
nanomolar
rang
regardless
whether
contain
endocytosi
solubl
form
receptor
bind
signal
internalis
crosslink
oligomer
su
anchor
tm
cell
multipl
vap
virion
surfac
somewhat
higher
howin
case
viral
bind
site
receptor
may
coincid
bind
site
physiologsurfac
howev
number
case
specif
ical
ligand
eg
epsteinbarr
viru
complement
vapreceptor
interact
requir
facilit
factor
bind
overlap
site
complement
viral
entri
specif
receptor
interact
may
receptor
chemokin
bind
corequir
initi
conform
chang
receptor
hiv
see
inhibit
viru
entri
event
lead
fusion
penetr
though
ligandinduc
receptor
exampl
interact
polioviru
solubl
endocytosi
may
involv
process
form
receptor
lead
partial
dissoci
partial
inhibit
physiolog
function
viral
capsid
structur
suggest
viru
receptor
vap
bind
describ
dock
receptor
may
role
aminoacid
phosphat
transport
moleunlock
capsid
structur
allow
viral
cule
serv
receptor
sever
retrovirus
rna
addit
use
cell
surfac
compon
viru
receptor
may
tether
virion
cell
entri
exampl
vap
bind
specif
cellular
receptor
function
exact
natur
addit
interact
viral
entri
exampl
friend
erythroleukeagain
vari
differ
virus
hiv
interacmia
viru
vap
bind
erythropoietin
receptor
tion
chemokin
receptor
bind
activ
receptor
mediat
inappear
essenti
fusion
see
fection
herp
simplex
viru
hsv
heparansulph
glycosaminoglycan
function
recruit
viru
altern
receptor
novel
tumour
necrosi
factor
nerv
growth
factor
receptor
homologu
appear
mani
system
virus
appear
bind
directli
requir
entri
similarli
initi
high
cell
surfac
molecul
mediat
internalisaaffin
bind
adenoviru
unknown
receptor
tion
penetr
consid
prii
mediat
viral
fibr
protein
viru
mari
receptor
absenc
primari
use
argglyasp
repeat
penton
base
proreceptor
virus
may
use
cell
surfac
comtein
bind
vitronectin
receptor
b
b
v
v
ponent
entri
fig
compon
may
conform
chang
vitronectin
receptor
less
effici
primari
receptor
nevertheless
requir
ligandinduc
receptor
internalisathey
compet
entri
molecul
tion
unclear
whether
penton
base
regard
altern
receptor
sfv
mhc
protein
induc
similar
chang
trigger
endoclass
antigen
propos
receptor
cytosi
altern
mechan
thu
yet
viru
clearli
infect
mhc
class
although
viru
abl
adher
cell
neg
cell
suggest
least
one
surfac
second
receptor
essenti
endocytosi
altern
receptor
exist
relat
sindbi
infect
case
suggest
viru
laminin
receptor
implic
term
coreceptor
use
evid
viru
attach
entri
unclear
direct
interact
virion
cofactor
whether
molecul
also
bind
sfv
role
second
compon
indirect
primat
lentivirus
unknown
chemokin
receptor
requir
entri
suffici
allow
viru
bind
cell
coreceptor
primat
lentivirus
chemokin
receptor
requir
fusion
insoon
identif
receptor
fection
regard
coreceptor
entri
becam
appar
addit
cell
see
strain
hiv
howev
abl
surfac
compon
requir
fusion
infect
neg
cell
virus
use
infect
express
human
murin
nih
orphan
chemokin
receptor
cell
exampl
fail
elicit
infect
entri
situat
wherea
express
hela
cell
render
chemokin
receptor
could
regard
altern
cell
permiss
togeth
data
suggest
receptor
provid
alon
mediat
bind
requir
least
one
factor
infect
fusion
also
use
galactosylceramid
also
recognis
infect
neural
intestin
neg
cell
might
multipl
accessori
factor
primat
line
whether
glycolipid
mediat
entri
lentivirus
shown
differ
capac
requir
addit
factor
unclear
howinfect
differ
cell
isol
earli
ever
regard
altern
albeit
ineffith
cours
infect
usual
infect
macroci
hiv
receptor
phage
primari
cell
seldom
tcell
line
contrast
mani
tcell
lineadapt
strain
viru
coreceptor
virus
isol
patient
advanc
diseas
infect
macrophag
virus
appar
initi
accessori
factor
identifi
receptor
interact
tether
role
found
member
famili
sevenaddit
cell
surfac
molecul
must
transmembran
gproteincoupl
chemokin
rerecruit
subsequ
step
entri
fig
ceptor
see
ref
initi
suggest
contrast
c
hiv
env
protein
capac
interact
coreceptor
blue
alon
without
requir
primari
receptor
bind
primari
receptor
still
occur
obligatori
chemokin
receptor
might
involv
viru
entri
chemokin
stromal
cell
deriv
factor
came
identif
cc
b
chemokin
chemokin
receptor
later
rant
hivsuppresidentifi
coreceptor
variou
strain
sive
factor
secret
cell
siv
particular
bind
thermor
lymphocyt
individu
rant
use
primari
multipli
expos
remain
uninmacrophag
tropic
strain
siv
fect
show
resist
infect
macrovirus
phage
tropic
form
associ
use
dualtrop
viru
viru
increas
secret
rant
mipinfect
lymphocyt
macrophag
subsequ
chemokin
receptor
discuss
chemokin
chemokin
receptor
call
previous
term
lestr
see
ref
humstr
fusin
identifi
entri
virus
isol
earli
infect
cofactor
cell
lineadapt
appear
respons
transmiss
sinc
shown
bind
cxc
macrophag
tropic
utilis
coreceptor
mutant
allel
postbind
event
identifi
mutat
caus
frameshift
truncat
fourth
adsorpt
viru
cell
surfac
transmembran
domain
mutant
protein
interact
specif
receptor
initi
event
express
cell
surfac
thu
lead
fusion
penetr
virus
cell
homozygot
mutat
undergo
fusion
cell
surfac
receptor
engagegener
suscept
infect
macrophag
ment
may
initi
molecular
rearrang
tropic
virus
though
infect
lead
penetr
virus
fuse
intracelbi
cell
lineadapt
virus
togeth
lularli
bind
result
uptak
virion
find
indic
import
endocyt
vesicl
transmiss
infect
popul
express
cell
usual
requir
penetr
cell
surfac
viru
establish
infect
precis
mode
molecul
plasma
membran
princip
barrier
function
togeth
facilit
viru
entri
viru
must
cross
access
cell
howev
unclear
discuss
primat
lentivirus
membran
may
obstacl
phindepend
entri
viru
tackl
mani
cell
contain
highli
organis
fusogen
envelop
glycoprotein
develop
cortic
cytoskeleton
plasma
env
virus
resembl
influenza
membran
see
ref
complex
actin
ha
see
fusion
env
contain
filament
actin
bind
protein
membran
bound
tm
nm
depth
capac
exclud
noncoval
associ
solubl
ribosom
organel
area
immesu
must
undergo
conform
chang
diat
adjac
plasma
membran
eukaryot
least
function
resembl
acidinduc
conribosom
sediment
coeffici
format
chang
trigger
ha
mediat
fusion
approxim
kd
size
howev
conform
chang
env
occur
comparison
preintegr
complex
hiv
neutral
ph
bind
induc
conformasediment
coeffici
thu
tional
chang
env
lead
exposur
cortic
cytoskeleton
potenti
restrict
epitop
associ
loop
movement
incom
viral
capsid
region
may
modul
interact
deeper
cell
sfv
fuse
surfac
chang
babi
hamster
kidney
cell
transient
drop
relat
fusion
still
investig
ph
medium
activ
fusion
infect
howev
view
emerg
cell
howev
maconform
chang
env
includ
reorientanipul
perform
chines
hamster
ovari
tion
loop
allow
env
complex
cell
viru
infect
though
bind
given
chemokin
receptor
endocyt
pathway
cortic
chemokin
receptor
complet
structur
develop
differ
extent
conform
chang
env
requir
fusion
differ
cell
type
exampl
bhk
cell
fig
mani
respect
like
cortex
well
develop
cho
cell
chemokin
receptor
essenti
viru
entri
seen
electron
micrograph
tissu
cultur
strain
viru
dispens
cortex
barrier
penetr
virus
need
still
requir
appropri
develop
strategi
bypass
structur
chemokin
receptor
thu
role
endocyt
rout
may
provid
one
mecharecruit
viru
cell
surfac
induc
nism
though
molecular
basi
establish
format
chemokin
receptor
bind
site
endocyt
vesicl
pass
cortex
su
well
establish
env
gener
endocyt
pathway
hostil
chemokin
receptor
gener
essen
viru
lysosom
primari
site
tial
hiv
entri
specif
role
addit
cellcellular
degrad
need
penetr
cortex
surfac
molecul
yet
rule
may
one
drive
forc
led
virus
use
low
ph
mean
delay
trigger
fusion
size
particl
internalis
endocytosi
thu
even
phindepenthrough
coat
vesicl
like
limit
sfv
dent
virus
endocytos
virion
may
virion
nm
diamet
easili
advantag
far
travers
cortex
accommod
coat
vesicl
larger
virion
concern
virion
fuse
cell
surfac
influenza
viru
hiv
approx
nm
diamhow
virus
fuse
cell
surfac
eter
also
enter
vesicl
rhabpenetr
cortex
present
littl
indovirus
vsv
howev
latter
elliptiform
hiv
virionassoci
proteas
cal
virion
long
axi
approxim
known
cleav
cellular
protein
addit
nm
tend
internalis
slowli
compar
gag
gene
product
among
cellular
sfv
possibl
reflect
difficulti
enter
protein
actin
sever
actinbind
protein
coat
vesicl
perhap
lentivirus
use
prononclathrin
mediat
endocytosi
also
teas
penetr
cortex
implic
constitut
endocytosi
molecular
mechan
involv
format
endocytosi
vesicl
well
characteris
situat
pathway
appear
upregul
cell
capac
endocytosi
respons
inhibit
clathrinmedi
endothrough
sever
distinct
mechan
although
endocytosi
unclear
basal
level
cytic
rout
viru
entri
long
propos
function
pathway
nonperturb
cell
becam
clear
endocytosi
could
bhk
least
clathrinco
vesicl
mediat
essenti
viru
infect
pathway
bulk
constitut
endocytosi
sfv
entri
determin
mani
cell
take
particul
ligand
clathrinco
vesicl
nm
diphagocytosi
although
promin
amet
form
invagin
coat
pitsspecialis
cell
monocyt
neutrophil
plasma
membran
domain
coat
complex
phagocytosi
limit
cell
clathrin
adaptor
depend
cell
process
receptormedi
initi
type
mani
hundr
vesicl
may
form
appropri
cell
surfac
receptor
complex
minut
cell
cycl
polyval
ligand
receptor
ligat
lead
main
conduit
receptormedi
endocytosi
activ
signal
cascad
involv
tyrosin
fluidphas
endocytosi
constitut
membran
kinas
enzym
drive
polymeriturn
follow
bud
clathrin
coat
sation
actin
cytosol
face
membran
remov
action
uncoat
adjac
adsorb
particl
actin
polyatpas
vesicl
fuse
earli
endosom
meriz
push
membran
around
particl
endosom
membran
content
allow
engag
receptor
recycl
cell
surfac
deliv
culmin
engulf
particl
phagocellular
destin
includ
late
endosom
cytosi
strictli
atp
depend
block
lysosom
golgi
apparatu
specialis
inhibitor
tyrosin
kinas
activ
actin
cell
synapt
vesicl
mhc
class
iicontain
polymeris
compart
altern
plasma
membran
gener
phagocytosi
involv
uptak
domain
see
ref
review
earli
endosom
larg
particl
cell
opsonis
acidifi
approxim
ph
bacteria
includ
within
clathrinmembraneassoci
vatpas
late
endosom
coat
vesicl
whether
role
entri
lysosom
acid
internalis
virus
unclear
influenza
virion
seen
ligand
en
rout
lysosom
transit
increasingin
uncoat
vesicl
close
oppos
vesicl
ly
acid
compart
virus
may
exploit
ph
membran
reminisc
phagocyt
vesicl
gradient
facilit
deliveri
specif
site
possibl
larger
virion
cell
poxvirus
internalis
phagocyt
vesicl
follow
phagosom
format
vesicl
microtubuleorganis
centr
may
interact
fuse
endosom
lysosom
acquir
er
vatpas
enzym
capabl
hydrolys
morpholog
studi
indic
phagocyt
content
acquisit
vatpas
taken
small
vesicl
deliv
directli
caus
phagocyt
vesicl
becom
er
nuclear
membran
recent
studi
acid
therebi
enabl
fusion
potenti
acidshown
vesicl
caveola
depend
virus
activ
believ
use
mhc
class
antigen
receptor
earli
morpholog
studi
show
class
antigen
could
associ
small
macropinocytosi
clathrin
coat
invagin
plasma
memmacropinocytosi
involv
format
usubran
retrospect
invagin
might
alli
larg
vesicl
region
plasma
membran
caveola
howev
class
antigen
ruffl
process
induc
also
implic
receptor
sfv
treat
cell
growth
factor
phorbol
ester
viru
clearli
use
clathrinmedi
rout
appear
constitut
activ
macroendocytosi
thu
mhc
class
antigen
might
phage
dendrit
cell
impliinternalis
differ
endocyt
rout
cate
pathway
present
exogen
differ
virus
might
direct
receptor
antigen
mhc
class
molecul
specif
endocyt
carrier
possibl
associawith
phagocytosi
format
macropinocyt
tion
coreceptor
molecul
although
vesicl
involv
actin
polymer
lead
implic
entri
role
caveola
deliveri
internalis
ligand
late
endosom
uptak
virus
remain
establish
lysosom
howev
process
liganddriven
appear
requir
activ
fusion
mechan
specif
receptor
role
macropinocytosi
viral
infect
unknown
howev
constitut
regardless
locat
critic
event
macropinocyt
activ
may
predispos
monocyt
penetr
envelop
virus
fusion
currentand
dendrit
cell
infect
virus
ly
fusion
reaction
trigger
influenza
ha
hiv
particular
also
spike
glycoprotein
sfv
dissect
consider
detail
caveola
influenza
viru
system
provid
best
model
caveola
small
nm
flaskshap
plasma
cellular
membran
fusion
extens
membran
invagin
long
recogdiscuss
viral
fusion
mechan
see
ref
nise
capillari
endothelia
cell
recent
evid
suggest
structur
widespread
role
cluster
influenza
viru
fusion
signal
pathway
associ
gpilink
membran
protein
integr
structur
influenza
viru
particl
caveola
appear
depend
presenc
influenza
viru
envelop
carri
three
differ
cholesterol
cholesterolbind
protein
transmembran
protein
ha
approx
copi
caveolin
initi
propos
per
virion
ii
neuraminidas
naapprox
structur
might
transient
invagin
process
copi
per
virion
iii
protein
small
term
photocytosi
recent
becom
tetramer
protein
present
low
copi
number
per
appar
caveola
undergo
actindepend
virion
ha
alon
requir
internalis
cell
treat
phosphatas
fusion
inhibitor
okada
acid
role
internalis
uncertain
evid
haemagglutinin
ha
synthesi
struccaveola
deliv
endocyt
pathway
ture
howev
internalis
caveola
appear
reloha
assembl
er
infect
cell
cate
perinuclear
region
adjac
singl
precursor
polypeptid
hao
approxim
amino
acid
protein
undergo
nlink
membran
fusion
protein
purifi
glycosyl
trimeris
fold
within
homogen
viru
suspens
fusion
protein
fold
correctli
compet
reconstitut
artifici
memit
releas
er
qualiti
control
system
brane
express
alon
cell
transport
golgi
plasma
membran
absenc
viral
protein
furthermor
water
fold
assembl
ha
studi
solubl
bromelaincleav
fragment
ha
bha
extens
involv
combin
activ
fragment
initi
use
deriv
crystal
set
er
chaperon
en
rout
structur
neutral
ph
conform
though
cell
surfac
oligosaccharid
modifi
fusioncompet
undergo
number
complex
form
hao
molecul
conform
chang
associ
fusion
proteolyt
cleav
furin
furintyp
enstudi
directli
correl
kinet
zyme
tran
golgi
cisterna
tran
golgi
phinduc
chang
conform
ha
network
gener
subunit
membran
fusion
suggest
follow
sequenc
xray
structur
ha
show
matur
protein
event
exposur
low
ph
induc
rapid
chang
contain
two
domain
globular
head
assemin
tertiari
structur
ha
involv
least
two
bled
contain
sialic
acidbind
step
first
exposur
fusion
site
ii
stalk
domain
compos
primarili
peptid
may
insert
target
membran
support
head
domain
cleav
possibl
viral
membran
well
age
newli
gener
n
terminu
con
short
lag
phase
lipid
mix
tain
stretch
conserv
hydrophob
residu
detect
final
subunit
dissoci
term
fusion
peptid
segment
detect
loss
epitop
form
crucial
fusion
noncleav
ha
molecul
adjac
subunit
ii
exposur
epitop
fusioncompet
neutral
ph
form
ha
initi
face
insid
stem
iii
fusion
peptid
buri
away
solvent
within
unmask
proteolyt
site
stalk
structur
nm
viral
membran
cleavag
part
provid
mechahow
exactli
chang
ha
occur
nism
allow
ha
trimer
transit
acid
allow
molecul
interact
membran
compart
exocyt
pathway
also
induc
fusion
still
unclear
posit
like
correct
fold
assembl
trimer
fusion
peptid
neutral
ph
close
viral
achiev
full
length
precursor
membran
initi
pose
topolog
problem
protein
sequenc
form
two
long
anti
could
fusion
peptid
interact
target
parallel
helic
link
loop
region
membran
locat
away
flank
helic
contain
sever
leucinezipp
model
studi
suggest
fusion
heptad
repeat
protein
similar
sequenc
loop
structur
adjac
molecul
show
propens
form
coil
coil
discuss
releas
proton
residu
involv
appear
least
part
ha
maintain
trimer
structur
would
refold
conform
chang
fusion
involv
form
energet
favour
tripl
refold
loop
region
form
coil
coil
strand
coil
coil
chang
would
creat
long
thu
ha
protein
regard
extend
helix
therebi
reloc
fusion
pepspringload
ie
full
length
hao
assemtid
within
stalk
end
rod
bled
metast
conform
refold
could
potenti
interact
target
cleavag
critic
stimulu
exposur
membran
support
model
came
low
ph
appli
resolut
structur
acid
form
fragment
structur
show
hamedi
membran
fusion
reorganis
loop
ahelix
relocaha
thu
form
nm
rodlik
structur
tion
fusion
peptid
tip
molecul
express
cell
surfac
incorpor
howev
addit
chang
occur
juxtavirion
assembl
mani
featur
made
membran
end
molecul
part
long
helix
protein
ideal
tool
studi
proteininduc
neutralph
structur
reloc
becom
antiparallel
rest
helix
thu
pressur
bilay
drive
hemifus
longitudin
helix
prolong
intermedi
full
fusion
full
fusion
straighten
n
terminu
truncat
proce
format
narrow
nm
bend
c
terminu
evid
support
diamet
pore
detect
patch
chang
nativ
ha
gain
clamp
techniqu
initi
pore
electron
microscopi
howev
inform
format
follow
short
lag
preced
lipid
structur
c
termin
region
still
mix
initi
fusion
pore
flicker
open
miss
orient
acid
form
close
widen
protein
respect
viral
membran
uncerallow
first
movement
lipid
subsequ
tain
em
studi
like
earlier
photoaffin
aqueou
content
fuse
cell
mix
label
studi
suggest
fusion
peptid
might
interact
hacontain
semliki
forest
viru
brane
ie
stage
least
acid
form
protein
might
invert
structur
synthesi
togeth
data
suggest
exposur
low
ph
limit
xray
crystallograph
data
exist
might
allow
fusion
peptid
swing
alphavirus
nevertheless
structur
inform
locat
within
stalk
perhap
driven
gain
imag
analysi
cryopreserv
initi
event
involv
refold
loop
virus
em
alphavirus
sfv
region
event
may
culmin
form
close
relat
sindbi
viru
uniform
protein
seen
lowph
crystal
structur
size
approxim
nm
diamet
regularli
fusioncompet
form
could
intermedi
shape
sfv
nucleocapsid
compris
one
rna
seri
chang
exposur
molecul
copi
capsid
c
protein
fusion
peptid
ha
protein
tip
fusion
capsid
protein
interact
viral
rna
peptid
could
interact
target
memeach
form
icosahedr
nucleocapsid
brane
virion
membran
keep
surfac
lattic
sfv
enlabel
studi
ie
protein
may
adopt
velop
contain
spike
glycoprotein
spike
tilt
conform
parallel
viral
consist
three
heterodim
small
target
membran
electron
peptid
result
proteolyt
cleavag
paramagnet
reson
studi
suggest
see
lost
sindbi
viru
spike
coil
coil
could
insert
remain
noncoval
attach
sfv
spike
membran
howev
photo
affin
label
complex
spike
triangular
form
like
indic
fusion
peptid
insert
nucleocapsid
icosahedr
shell
chang
ha
induc
reorganis
surfac
lattic
suggest
spike
oppos
lipid
bilay
also
still
unclear
glycoprotein
heterodim
directli
interact
unlik
fusion
pore
form
singl
capsid
protein
interact
appear
ha
trimer
current
data
suggest
mediat
conserv
tyrosin
minimum
three
ha
trimer
requir
form
cytoplasm
domain
hydrophob
pocket
function
fusion
complex
transon
capsid
protein
chemic
crossmembran
domain
ha
crucial
fusion
use
link
studi
sindbi
viru
suggest
cellto
cell
fusion
assay
ha
molecul
anchor
spike
contain
inner
core
three
subunit
membran
gpi
moieti
rather
outer
shell
form
three
subunit
usual
transmembran
domain
induc
hemifuan
arrang
confirm
cryoelectron
microsiona
state
outer
inner
scopi
receptorbind
site
spike
leaflet
bilay
fuse
experi
complex
yet
identifi
howev
amphipath
select
insert
either
hydrophob
domain
amino
acid
inner
outer
leaflet
membran
chang
sfv
highli
conserv
alphavirus
curvatur
membran
suggest
believ
involv
fusion
normal
transmembran
domain
requir
exert
ha
alphaviru
spike
protein
assemactiv
indic
caviti
neutral
ph
bled
er
transport
cell
surfac
spike
complex
narrow
centriped
movewhen
fold
complet
spike
protein
ment
subunit
extend
toward
also
synthesis
precursor
form
protein
target
membran
contrast
subunit
sepaassembl
togeth
precursor
rate
role
chang
support
protein
three
dimer
subsequ
assembl
abil
monoclon
antibodi
recognis
form
spike
protein
complex
transport
epitop
expos
low
ph
form
cell
surfac
prior
arriv
plasma
inhibit
fusion
infect
membran
protein
cleav
cellular
structur
chang
preced
onset
fusion
proteas
gener
protein
found
monitor
lipid
mix
follow
matur
spike
glycoprotein
properti
conform
chang
describ
viru
matur
heterodim
distinctli
differ
acquir
capac
bind
cholesterolconfrom
precursor
dimer
exposur
tain
lipid
vesicl
though
sfv
complex
mildli
acid
condit
result
bind
cholesterolcontain
liposom
low
dissoci
subunit
wherea
comph
fuse
membran
unless
plex
dissoci
upon
exposur
ph
valu
contain
low
amount
mol
thu
appear
olipid
ceramid
minim
strucstabilis
immatur
spike
complex
prevent
tural
compon
sphingolipid
support
prematur
activ
transport
fusion
sfv
interact
cholesterol
mildli
acid
compart
exocyt
pathway
sphingolipid
stereospecif
cleavag
may
also
induc
conformamann
lipid
promot
sfv
fusion
tional
chang
heterodim
result
known
may
promot
addit
conformaform
exposur
receptorbind
site
sfv
tional
chang
requir
fusion
prevent
particl
carri
spike
uncleav
inactiv
fusionact
form
reduc
capac
bind
cell
thu
proteolyt
cleavag
sfv
spike
glycoprotein
virus
control
activ
viral
fusion
pattern
emerg
studi
sfv
potenti
viral
receptorbind
capac
influenza
viru
conform
chang
ininteract
sindbi
viru
cell
surfac
duce
low
ph
lead
format
stabl
receptor
may
initi
addit
conform
trimer
complex
subunit
envelop
chang
spike
glycoprotein
protein
respect
studi
although
chang
might
role
flavi
viru
tickborn
enceph
viru
tbe
enhanc
bind
prepar
spike
structur
vap
fusion
protein
protein
fusion
unlik
essenti
resolv
suggest
molecul
also
fusion
sfv
least
fuse
pure
lipid
rearrang
form
stabl
trimer
low
phmembran
ph
lower
appropri
induc
fusion
contrast
sfv
influenza
viru
spike
protein
ha
respect
form
trimer
structur
project
sfv
fusion
membran
tbe
envelop
protein
follow
exposur
low
ph
rearrang
dimer
orient
parallel
viral
membran
sfv
spike
protein
initi
dissociathu
viru
trimer
format
fusion
tion
subunit
involv
extens
reorganis
fusion
proreleas
monom
reorganis
homottein
subunit
rimer
mask
trypsin
cleavag
site
chang
antigen
retroviru
fusion
epitop
parallel
case
retrovirus
phindepend
reorganis
spike
protein
observ
morfor
fusion
discuss
hiv
like
pholog
timeresolv
imag
sfv
ph
aspect
envelop
proteinreceptor
interact
activ
fusion
bind
alva
current
comparison
ha
regard
receptor
viral
envelop
protein
complex
caution
nevertheless
sever
studi
shown
induc
conform
chang
suggest
retrovir
envelop
protein
sutm
complex
sever
primari
reform
trimer
retrovir
transmemceptor
retrovirus
well
coreceptor
brane
protein
contain
n
termin
hydrophob
sefor
primat
lentivirus
multimembran
quenc
resembl
ha
fusion
peptid
fig
span
protein
suggest
properti
furthermor
domain
heptad
repeat
class
protein
might
facilit
retrovir
fusion
implic
fusion
synthet
pephowev
least
two
retrovirus
bovin
leukaemia
tide
repres
sequenc
ctermin
fusion
viru
avian
leukosi
viru
use
multipeptid
strong
propens
form
helic
membran
span
protein
receptor
tabl
solut
henc
specul
similar
organis
retrovir
enthat
receptor
bind
unleash
conform
velop
protein
influenza
ha
suggest
aschang
involv
format
coil
coil
pect
retroviru
orthomyxoviru
fusion
may
exposur
tm
fusion
peptid
similar
howev
structur
nativ
synthet
peptid
repres
retrovir
envelop
protein
yet
solv
hiv
heptad
repeat
block
viru
entri
perhap
two
precursor
polypeptid
chain
repres
ntermini
left
ctermini
right
hiv
env
encompass
approxim
residu
influenza
ha
ctermini
molecul
cytoplasm
intravirion
cytoplasm
domain
hiv
env
consider
longer
ha
repres
segment
right
transmembran
domain
transport
cell
surfac
precursor
cleav
prerequisit
subsequ
fusion
activ
two
result
polypeptid
chain
hiv
env
su
surfac
tm
transmembran
noncoval
associ
influenza
viru
link
disulphid
bond
intrachain
disulphid
bond
mark
su
respons
bind
respect
virus
cell
surfac
receptor
sialic
acid
receptorbind
site
creat
juxtaposit
space
conserv
residu
noncontigu
aminoacid
sequenc
su
hiv
residu
situat
conserv
region
side
loop
loop
influenc
interact
chemokinereceptor
coreceptor
cleavag
precursor
creat
novel
ntermini
transmembran
protein
ntermin
peptid
share
similar
hydrophob
sequenc
implic
membran
fusion
ctermin
fusion
peptid
potenti
coil
region
two
hiv
tm
extracellular
domain
approx
residu
precursor
one
region
residu
region
propens
form
alpha
helic
may
form
coiledcoil
step
seri
event
activ
membranefus
capac
two
protein
interf
abil
region
influenza
virion
low
ph
proton
influx
oligomeris
fusion
reaction
acidifi
interior
virion
acidif
structur
alpha
helic
domain
exof
viral
core
presum
disrupt
phtracellular
portion
tm
solv
sensit
interact
matrix
protein
crystallograph
domain
form
trimer
rna
bind
nucleoprotein
np
two
interact
peptid
ntermin
peptid
therebi
allow
viral
rnp
transport
contain
heptad
repeat
form
trimer
nucleu
amantadin
weak
base
coil
coil
around
coil
coil
ctermin
accumul
endosom
interrupt
sepeptid
wound
fit
quenc
event
block
channel
function
hydrophob
groov
coil
coil
ture
might
posit
hiv
fusion
peptid
top
protrud
six
helix
bundl
fusion
sfv
peptid
could
insert
membran
structur
share
featur
low
ph
intracellular
part
alphaviru
replic
fragment
influenza
viru
ha
suggest
cycl
take
place
entir
cytoplasm
infecrepres
core
fusion
activ
replic
occur
associ
membran
late
endosom
lysosom
er
thu
viral
rna
appear
remain
earli
postpenetr
event
ate
compart
viru
fuse
fusion
fate
nucleocapsid
vari
accord
destin
viru
within
hiv
cell
multipl
mechan
illustr
system
discuss
demonstr
abil
differ
contrast
retroviru
hiv
infect
virus
exploit
properti
host
cell
nondivid
cell
indic
hiv
special
requir
exampl
dna
provir
dna
reversetranscrib
genom
hsv
must
deliv
nucleu
rna
genom
abl
penetr
intact
although
mani
molecular
detail
remain
nuclear
membran
hiv
preintegr
complex
establish
seem
follow
fusion
contain
viral
matrix
protein
recent
tegument
protein
remov
capsid
studi
identifi
nuclear
target
signal
remain
intact
bind
cytoplasm
dynein
use
similar
previous
characteris
cellular
microtubul
system
transloc
cellular
viral
protein
link
perinuclear
region
locat
capsid
plasma
membran
via
ntermin
myrist
acid
bind
directli
nuclear
pore
dna
group
howev
phosphoryl
deliv
nucleu
without
complet
disassembmultipl
serin
tyrosin
residu
phosphorylali
capsid
tion
displac
membran
manner
similar
demonstr
marck
influenza
viru
protein
thu
macontain
viral
preintegr
complex
like
releas
case
influenza
viru
acidif
plasma
membran
phosphoryl
viral
core
requir
cellular
infect
natur
kinas
involv
phosphorylenvelop
influenza
virion
contain
small
number
ation
event
unclear
serin
threonin
protein
molecul
function
proton
tyrosin
kinas
activ
detect
highli
channel
exposur
purifi
hiv
virion
thu
viru
may
packag
cellular
kinas
assembl
facilit
protein
proven
effect
deliveri
vehicl
subsequ
target
nucleu
dna
drug
peptid
toxin
tissu
cultur
releas
complex
transport
initi
studi
suggest
also
work
nuclear
membran
nucleophil
signal
anim
model
deliveri
peptid
presum
allow
interact
nuclear
pore
cytoplasm
cell
present
mhc
class
unclear
discuss
cortic
cytoskeleton
antigen
futur
studi
undoubtedli
allow
may
present
barrier
viral
capsid
effect
use
vector
develop
travers
section
viral
encod
protein
includ
integras
product
vpr
gene
also
present
preintegr
complex
though
capsid
protein
vpr
also
appear
acknowledg
requir
infect
nondivid
cell
nuclear
target
signal
identifi
author
support
grant
protein
although
karyophil
unit
kingdom
medic
research
council
imposs
vpr
protein
preintegr
complex
function
bring
incom
viral
preintegr
complex
refer
plasma
membran
nucleu
interact
cellular
transport
pathway
reach
stage
clinic
trial
review
see
virol
ref
vector
base
retrovirus
adeno
kb
andersen
h
skov
retrovirusinduc
cell
fusion
enhanc
proteas
treatment
j
gen
virol
herpesvirus
allow
stabl
integra
tion
express
given
gene
prove
iexpress
cell
virosom
contain
nonprim
cell
human
cell
j
virol
reconstitut
influenza
sendai
vsv
ebv
fusion
